{"cik":1645666,"taxonomy":"us-gaap","tag":"DeferredIncomeTaxExpenseBenefit","label":"Deferred Income Tax Expense (Benefit)","description":"Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.","entityName":"Kezar Life Sciences, Inc.","units":{"USD":[{"start":"2018-01-01","end":"2018-12-31","val":0,"accn":"0001564590-19-009369","fy":2018,"fp":"FY","form":"10-K","filed":"2019-03-26","frame":"CY2018"},{"start":"2019-01-01","end":"2019-12-31","val":0,"accn":"0001564590-20-010498","fy":2019,"fp":"FY","form":"10-K","filed":"2020-03-12","frame":"CY2019"},{"start":"2020-01-01","end":"2020-12-31","val":0,"accn":"0001564590-21-012525","fy":2020,"fp":"FY","form":"10-K","filed":"2021-03-11","frame":"CY2020"},{"start":"2021-01-01","end":"2021-12-31","val":0,"accn":"0000950170-22-004085","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-17","frame":"CY2021"},{"start":"2022-01-01","end":"2022-12-31","val":0,"accn":"0000950170-23-007871","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-14","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":0,"accn":"0000950170-24-031494","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-14"},{"start":"2023-01-01","end":"2023-12-31","val":0,"accn":"0001628280-26-021737","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-27","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":0,"accn":"0001645666-25-000010","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-25"},{"start":"2024-01-01","end":"2024-12-31","val":0,"accn":"0001628280-26-021737","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-27","frame":"CY2024"},{"start":"2025-01-01","end":"2025-12-31","val":0,"accn":"0001628280-26-021737","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-27","frame":"CY2025"}]}}